ABC-S
Acoustic Blood Cells Sorter
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0ABC-S project word cloud
Explore the words cloud of the ABC-S project. It provides you a very rough idea of what is the project "ABC-S" about.
Project "ABC-S" data sheet
The following table provides information about the project.
| Coordinator |
AENITIS TECHNOLOGIES
Organization address contact info |
| Coordinator Country | France [FR] |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3.1.3. (Treating and managing disease) |
| Code Call | H2020-SMEINST-1-2016-2017 |
| Funding Scheme | SME-1 |
| Starting year | 2016 |
| Duration (year-month-day) | from 2016-08-01 to 2016-12-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | AENITIS TECHNOLOGIES | FR (MITRY MORY) | coordinator | 50˙000.00 |
Map
Project objective
Aenitis Technologies develops innovative solutions for separating, sorting and filtration of cells in suspension based on patented acoustophoresis technologies (pheresis based on acoustic radiation forces influence on polydisperced suspension). Aenitis’ first axis of development is an innovative blood fractionation medical device for the production of labile blood products (LBP). It will overtake limits of currently used centrifugation processes which have many adverse effects as platelet activation (mainly due to induced shear forces). Aenitis approach revolutionizes the sector as it permit in a secure and simple process to product LBP. It also avoids platelet activation as shear forces are very low in acoustophoresis process. This innovative Acoustic Blood Cells Sorter (ABC-S) project is highly recognized and awarded. It will solves major healthcare issues in LBP preparation by developing an innovative instrument capable of fractionating blood in continuous, without contact or pressure and with very low shear forces, to produce from whole blood high quality LBP. It will include the development of a platelet concentrate quality then unequalled in the world with a potentially conservation time significantly increased. This medical device will be associated with a disposable medical device to the source of recurring revenue. Blood medical devices world market is estimate to $14 Billion with an average growth annual rate of 5.5%. Yearly, 108 million blood donations are processed worldwide, including over 300 million in Europe and 460 million in North America. Our technology will have major impact for all blood banks’ LBP production; inducing a new gold standard driven by Europe. This proposal for the call H2020 SME Instrument Phase 1 “Supporting innovative SMEs in the healthcare biotechnology sector: Cell technologies in medical applications” will permit Aenitis to grow from a functional laboratory-scale prototype to preindustrial prototypes first steps.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ABC-S" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ABC-S" are provided by the European Opendata Portal: CORDIS opendata.